Simplified Chinese
06
2022-12
Minhai Biotechnology’s Academician and Expert Workstation Has Been Recognized as Outstanding.
On December 2, the Beijing Association for Science and Technology issued a notice announcing the results of the 2022 performance evaluation for Beijing’s Academician and Expert Workstations (Document No. Jing Ke Xie Fa [2022] No. 70). Our company’s Academician and Expert Workstation was rated “Excellent” thanks to its well‑established organizational framework, solid progress in implementation, and outstanding innovation outcomes. Among the 75 Beijing Academician and Expert Workstations that passed this evaluation, only 10 received an “Excellent” rating. Since its establishment in 2014, Minhai Biotechnology’s Academician and Expert Workstation has continuously refined its organizational structure and management processes in accordance with regulations such as the Measures for the Administration of Academician and Expert Workstations, ensuring robust institutional safeguards.
31
2022-10
On the morning of October 26, 2022, the “2022 Academic Salon of the Academician and Expert Service Center—Seminar on Novel Viral Vaccines,” hosted by the Beijing Association for Science and Technology and co-organized by the Innovation Service Center of the Beijing Association for Science and Technology and Beijing Minhai Biotechnology Co., Ltd., was held at Minhai Biotechnology. Eight renowned experts in the vaccine field, including Academician Yongxin Yu of the Chinese Academy of Engineering, were invited to attend and deliver remarks. The salon adopted a hybrid format, combining online and offline participation, and was chaired by Liu Jiankai, Executive Deputy General Manager of the company. Zheng Haifa, Director of the Academician and Expert Workstation, provided an overview and summary of the event. Attending academicians and specialists…
31
2022-10
On October 26, the World Life Sciences Conference—China–South Africa Life Sciences Industry Project Matchmaking Meeting opened at the Zhongguancun South Africa Science and Technology Park in Johannesburg, South Africa. Zhang Qian, General Manager of the International Affairs Department of Shenzhen Kangtai Biological Products Co., Ltd., attended the conference and delivered a speech. He briefed the attendees on the company’s development history, product portfolio, and international collaborations, provided an update on its current R&D progress, and expressed Kangtai Biological’s sincere intention to partner with South African enterprises, hoping to make a meaningful contribution to advancing the life sciences and health industries between China and Africa. Daandu Toit, Deputy Director-General of South Africa’s Department of Science and Innovation, …
21
2022-10
On the afternoon of October 19, 2022, the kickoff meeting for the guidance work on establishing healthy enterprises in Daxing District was successfully held at our company. Attendees included Li Yuxiang, Director of the Occupational Health Division of the Beijing Municipal Health Commission; Li Gang, Deputy Section Chief of the Public Health Section of the Daxing District Health Commission; Wei Shanfeng, Vice Chairman of the China Occupational Safety and Health Association; appointed experts Wang Zhongxu, Lü Lin, and Hu Lan; Zhou Ruigang, Deputy General Manager of the Management Committee of the Daxing District Biopharmaceutical Industry Base; Song Xinlei, Head of the Safety Section; as well as Zheng Haifa, General Manager of Beijing Minhai Biotechnology Co., Ltd.; Zhang Zhiguang, General Manager of Beijing Yiling Pharmaceutical Co., Ltd.; and Jin Yiqun, Executive Deputy General Manager of Beijing Wuhe Bo’ao Pharmaceutical Co., Ltd., among others.
20
2022-10
To ensure epidemic prevention and the safe management of hazardous chemicals during the period of the 20th National Congress, on the morning of October 18, 2022, Cai Xiaojun, a member of the Party Leadership Group and Deputy District Mayor of the Daxing District Government, led a team to the company for an inspection of epidemic prevention measures and workplace safety. Also present were Wang Qunhui, Party Secretary and Director of the Science and Technology Commission of Daxing District; Feng Mixiang, Deputy Director; Zhou Ruigang, Deputy General Manager of the Biomedical Base Management Committee; and Song Xinlei, Head of the Safety Division of the Biomedical Base Management Committee. The company’s General Manager Zheng Haifa, along with Wu Chengyu, Zhang Yidi, and other company representatives, accompanied the inspection. The inspection team focused on verifying the implementation of the company’s epidemic prevention protocols, as well as the safe storage, use, and management of hazardous chemicals. The inspection team requested…